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Alterations  in  liver  vascular  tone  play an  important  role  in  chronic  liver  disease.  The  hep-
atic stellate  cell  (HSC)  and  mediators  such  as nitric oxide  (NO)  and hydrogen  sulﬁde  (H2S)
have been  implicated  in regulation  of  vascular  tone  and  intra-hepatic  pressure.  Though
these  have  been  studied  in  chronic  liver  damage,  changes  in  response  to acute  liver injury
induced  by  hepatotoxins  such  as  dimethyl  nitrosamine  are  not  well  understood.  Liver  injury
was induced  in  mice  by  a single  intra-peritoneal  injection  of  dimethylnitrosamine  (DMN),
following  which  animals  were  sacriﬁced  at  24, 48 and 72  h. Changes  in vascular  mediators
such  as NO  and  H2S as  well  as  stellate  cell  activation  was  then  examined.  It was  found
that  a  single  low  dose  of DMN  in  mice  is sufﬁcient  to  induce  activation  of  hepatic  stellate
cells within  24  h, accompanied  by oxidative  stress,  compromised  metabolism  of  H2S  and
decreased  levels  of the  von  Willebrand  factor  (vWF)  cleaving  protease;  a disintegrin  and
metalloproteinase  with  a  thrombospondin  type  1 motif,  member  13  (ADAMTS13),  which
functions  in intravascular  thrombosis.  A suppression  of  hepatic  NO levels  is  also initiated  at
this time  point,  which  progresses  further  and  is  sustained  up  to  72  h, at which  point  the HSC
activation  is  still  present.  Compromised  levels  of  ADAMTS13  and  H2S  metabolism  however,
begin to recover  by  48  h  and  are  almost  similar  to  control  by  72  h.  In conclusion,  these  data
suggest  that  even  moderate  acute  insults  in  the  liver  can have  far reaching  consequences
on  a number  of mediators  of  vascular  ﬂow  in  the  liver.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
Y-NC-Nthe CC  B
. IntroductionThe liver is a highly vascular organ, where regulation of
lood  ﬂow plays a critical role in synthetic and metabolic
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functions. Changes in liver vasculature and the resulting
alterations in blood ﬂow have far reaching consequences
not only in the liver, but also in other organs such as the
lungs  [1]. These alterations are typically seen in chronic
liver injury, where the resulting portal hypertension leads
to  complications of liver disease [2]. A number of molecu-
lar  mediators have been implicated in regulation of hepatic
vascular tone with nitric oxide being one of the most impor-
tant.  Nitric oxide (NO) has been shown to modulate hepatic
vascular tone in the normal rat liver [3] and NO is one of
several  vasoactive substances, which are activated in portal
 access article under the CC BY-NC-ND license (http://creativecommons.
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hypertension and are responsible for the marked splanch-
nic  vasodilatation seen [2]. Nitric oxide deﬁciency in the
liver  can lead to increased intra-hepatic resistance, while
increased NO in the circulation contributes to the hyper-
dynamic systemic/splanchnic circulation [4]. It has recently
been  demonstrated that NO acts in conjunction with hydro-
gen  sulﬁde (H2S) to carry out regulation of angiogenesis
and endothelium-dependent vasorelaxation [5] and cyto-
protective signaling mediated by H2S was found to be
dependent on NO generated by endothelial nitric oxide
synthase (eNOS) [6].
Hydrogen  sulﬁde is a water soluble small molecule,
which is synthesized by the action of the enzymes cys-
tathionine -synthase (CBS), cystathionine -lyase (CSE),
and  3-mercaptopyruvate sulfur transferase (3MST) [7]. CBS
and  CSE are expressed in many tissues, including the liver
[8]  and H2S has been suggested to be a potent modula-
tor of vascular tone and also a stimulator of angiogenesis
[9]. Hydrogen sulﬁde has also been shown to modulate
sinusoidal constriction and contribute to hepatic microcir-
culatory dysfunction during endotoxemia [10].
The liver is also an important source of proteins involved
in  the coagulation cascade, and plays a critical role in reg-
ulation  of clotting. The organ’s importance is illustrated by
the  impact on coagulation in liver disease, where patients
with  advanced liver diseases tend to bleed because of
reduced plasma levels of several clotting factors and throm-
bocytopenia [11]. In addition to various coagulation factors
produced in the liver, stellate cells in the organ are also the
site  of production of a disintegrin and metalloprotease with
a  thrombospondin type 1 motif, member 13 (ADAMTS13), a
protease  which speciﬁcally cleaves multimeric von Wille-
brand  factor (vWF) [12]. Circulating levels of ADAMTS13
levels have been shown to be signiﬁcantly lower in patients
in  a variety of liver diseases, including alcoholic hepatitis
[13]  and idiopathic non cirrhotic intrahepatic portal hyper-
tension  [14,15]. Circulating VWF  antigen levels were also
found  to be highly elevated in patients with acute liver
injury/acute liver failure accompanied by low ADAMTS13
levels [16].
Though alterations in these vascular factors in circula-
tion and liver have been studied after chronic liver injury
and  development of cirrhosis, information on their modu-
lation  at early time points induced by acute liver injury is
lacking.  This is important, since understanding these early
changes  would provide insight into key mechanistic fea-
tures  which may  be amenable to therapeutic interventions,
before irreversible changes in liver vasculature take place.
To  investigate this, we evaluated the temporal course of
these  vascular mediators in response to a single dose of the
hepatotoxin dimethylnitrosamine (DMN).
2. Materials and methods
2.1.  Animals and induction of liver injury by DMN
Black C57BL6 mice of both sexes (18–25 g), exposed
to a daily 12-h light–dark cycle and fed water and rat
chow ad libitum were used for the study. The study
was approved by the Institutional Animal Ethics Com-
mittee (IAEC). For induction of liver injury, mice wereogy Reports 1 (2014) 707–717
administered a single intraperitoneal injection of DMN
(10  mg/kg, ip), while control mice received the vehicle
methanol alone. Mice were then sacriﬁced 24, 48 or 72 h
after  DMN  treatment and blood was taken from the vena
cava  into a heparinized syringe for measurement of alanine
aminotransferase (ALT) activities (Autospan ALT kit, Span
Diagnostics Ltd., Surat, India). The liver was  removed and
rinsed  in saline; liver sections were ﬁxed in 10% phosphate-
buffered formalin for histological analyses. The remaining
liver  was snap-frozen in liquid nitrogen and stored at
−80 ◦C for further analysis.
2.2.  Liver histology and immunoﬂuorescence detection
Formalin-ﬁxed tissue sections were embedded in paraf-
ﬁn  and 4 m sections were cut. Replicate sections were
stained with hematoxylin and eosin (H&E) for evalua-
tion of liver injury. For immunoﬂuorescence, sections were
placed  on poly-l-lysine coated slides, following which
the  slides were deparafﬁnized and antigen retrieval per-
formed  (20 min  at 95 ◦C in 10 mmol/L sodium citrate
buffer, pH 6). Slides were then incubated either with
a  mouse monoclonal anti-nitrotyrosine antibody (1:100
dilution, Santa Cruz), a polyclonal rabbit anti-glial ﬁbril-
lary  acidic protein (GFAP) (1:400 dilution, DAKO) or a
polyclonal rabbit anti-ADAMTS13 (1:100 dilution, Santa
Cruz)  overnight at 4 ◦C. The sections were then incubated
with the corresponding secondary antibody for one hour
in  the dark. The nuclei were stained with 4′,6-diamidino-
2-phenylindole dihydrochloride (DAPI) (1:1000 dilution,
Sigma). The immunostained sections were then mounted
using Fluorogel with Tris buffer (Electron Microscopy
Sciences) and visualized under a confocal microscope
(Olympus FluoViewTM FV1000).
2.3. Nitrate measurements
Nitrate  in the samples was ﬁrst reduced to nitrite using
a  copper–cadmium alloy, which was then measured by
the  Griess reaction as described [17]. Samples were incu-
bated  with the alloy ﬁlings in carbonate buffer for 1 h at
room  temperature with shaking. The reaction was stopped
by  addition of 0.35 M NaOH and 120 mM ZnSO4 solu-
tion, followed by vortexing. After standing for 10 min,
the  samples were centrifuged at 4000 × g for 10 min.
0.5 ml  aliquots of the clear supernatant were treated
with 0.25 ml  of 1% sulfanilamide and 0.25 ml  of 0.1% N-
naphthylethylenediamine. After 10 min, the absorbance
was  read at 545 nm in a spectrophotometer. Amount of
nitrate  formed was  calculated using a standard curve pre-
pared  from sodium nitrate and expressed as nmoles/mg
protein.
2.4. Measurement of arginase activity
Arginase activity was measured by the conversion of
l-arginine to l-ornithine as described [18], with slight
modiﬁcations. Brieﬂy, liver homogenates were incubated
with 10 mM manganese chloride at 55 ◦C to activate avail-
able  arginase. Samples were then incubated at 37 ◦C for
10  min  in carbonate buffer (100 mM,  pH 10) containing
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00 mM l-arginine hydrochloride, followed by addition of
cetic  acid to stop the reaction. The color developed after
 further incubation at 100 ◦C for 60 min  in presence of
inhydrin solution was then measured at 515 nm on a spec-
rophotometer.
.5.  Quantitative real-time polymerase chain reaction
qRT-PCR)
Expression of the eNOS gene was quantiﬁed using
RT-PCR analysis as previously described [19] using the fol-
owing  primers – Fwd: 5′-TGTCACTATGGCAACCAGCGT-3′,
ev:  5′-GCGCAATGTGAGTCCGAAAA-3′. Brieﬂy, mice liver
NA  was extracted using the QIAGEN RNeasy mini kit and
DNA  synthesized using the QIAGEN Quantitect-Reverse
ranscription kit according to the manufacturer’s instruc-
ions.  The SYBR green PCR Master Mix  (KAPA Biosystems,
oston, MA)  was used for real-time PCR analysis. The
elative differences in expression between groups were
xpressed using cycle time (Ct) values. Ct values for the
ene  was ﬁrst normalized with that of RPL19, as a house-
eeping gene, in the same sample, and relative differences
etween groups were expressed as relative decrease, set-
ing  control as 100%.
.6.  Measurement of oxidant stress parameters
Malondialdehyde levels were estimated in liver samples
s  an indication of lipid peroxidation by measuring thio-
arbituric acid reactive substances (TBARS) as described
20]. Protein carbonyl content was used as a marker for
rotein  oxidation and was measured in samples using dini-
rophenyl  hydrazine (DNPH) as described [21].
.7. Isolation of liver mitochondria
The  liver was excised and homogenized with 8 volumes
f  homogenization buffer containing 230 mmol/L manni-
ol,  70 mmol/L sucrose, and 3 mmol/L HEPES and 1 mmol/L
DTA,  pH-7.4 using a Porter–Elvehjem homogenizer. Mito-
hondria  were prepared by differential centrifugation as
escribed  [22]. Brieﬂy, the liver homogenate was  ﬁrst
entrifuged at 600 × g for 10 min  to remove cell debris
nd mitochondria were pelleted at 15,000 × g for 5 min
nd  washed twice with mitochondrial suspension buffer
ontaining 230 mmol/L mannitol, 70 mmol/L sucrose and
 mmol/L HEPES at pH 7.4.
.8. Western blotting
Inducible  nitric oxide synthase (iNOS) protein lev-
ls  were quantitated by western blot analysis. Liver
omogenates (20 g protein) were separated on a 5–16%
radient SDS-PAGE gel using Tris–Glycine–SDS buffer.
fter electroblotting, the PVDF membranes were blocked
ith  5% skimmed milk in TBS/Tween 20 (0.02%) (TBST),
ollowing which the membrane was probed with a rab-
it  polyclonal anti-iNOS primary antibody (Santa Cruz
iotechnology) for 12 h at 4 ◦C. The secondary antibody
sed was an anti-rabbit (1:5000 dilution) IgG conju-
ated to horse radish peroxidase (HRP), followed byogy Reports 1 (2014) 707–717 709
enhanced chemiluminescence detection. As a loading con-
trol,  membranes were stripped and reprobed with mouse
monoclonal anti--actin (1:5000 dilution, Sigma) for 12 h
at  4 ◦C. The secondary antibody used was anti-mouse IgG
conjugated to horse radish peroxidase (HRP). Densitomet-
ric analysis of the bands was performed using Image J
software (NIH).
2.9.  Assay of liver H2S synthesis and rhodanese activity
Hydrogen  sulﬁde biosynthesis in the liver was
measured as described previously [23]. Brieﬂy, liver
homogenates in phosphate buffer were incubated with
l-cysteine and pyridoxal 5 phosphate, followed by trap-
ping  of the released H2S with zinc acetate. After treatment
with N,N-dimethyl-phenylenediamine sulfate and FeCl3,
the  absorbance at 670 nm was determined and the H2S
concentration calculated against a calibration curve of
NaHS.  Rhodanese activity in liver samples was determined
as  described previously [24].
2.10. In vitro oxidant exposure
For  examining the direct effect of oxidative stress on
mitochondrial rhodanese activity, normal liver mitochon-
dria  (200 g protein) was treated with hydrogen peroxide
(100 M)  for 30 min  at 37 ◦C. Following treatment, the
activity of rhodanese was estimated as mentioned above.
To  conﬁrm the role, if any, of hydrogen peroxide, exper-
iments were also carried out in the presence of catalase
(1000 units).
2.11.  Statistical analysis
Results  are expressed as mean ± SEM. Student’s t-test
was used for statistical analysis and a p value of less than
0.05  was taken to indicate statistical signiﬁcance.
3. Results
Treatment of C57BL6J mice with a single dose of
dimethylnitrosamine (DMN) at 10 mg/kg, resulted in mod-
erate  hepatocyte injury by 24 h as seen by the elevation
in ALT levels (Fig. 1A). This injury seems to be transient,
since ALT levels were found to be lowered by 48 and
72  h after DMN  administration. Liver histology indicated
normal hepatocellular architecture in controls. By 24 h,
perivenular necrosis was evident with hepatocytes show-
ing  microvesicular change. Cells around the portal tract
were  spared. Scattered neutrophils and lymphocytes were
seen.  By 48 h, these changes were resolving, with only scat-
tered  necrotic cells and a decrease in inﬂammatory cells. By
72  h, recovery was more pronounced with only occasional
inﬂammatory cells being seen (Fig. 1B).
Nitric oxide is a well known physiological vasodilator
and has been shown to be involved in modulation of intra-
hepatic  vascular tone. To evaluate if the low dose DMN
administration affected this mediator, the temporal course
of  liver nitrate was  evaluated. As seen in Fig. 2A, a decrease
in  NO levels was  evident as early as 24 h and reached sta-
tistical  signiﬁcance by 48 and 72 h after DMN  treatment.
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e point
.05). (B)Fig. 1. (A) Liver injury as assessed by circulating ALT levels at various tim
weight  dimethyl nitrosamine (DMN). Values are mean ± SEM, n = 4 (*p < 0
of  10 mg/kg body weight DMN.
DMN administration has been shown to induce genera-
tion of ROS [25] as well as iNOS [26], albeit when multiple
doses were used. To evaluate if a single injection could
also induce oxidative stress, parameters of lipid peroxi-
dation and protein oxidation were examined in the liver
at  various time points after DMN  treatment. A moderate
but signiﬁcant increase in malondialdehyde levels was evi-
dent  within 24 h, which was sustained also at 72 h (Fig. 2B),
though  no change in liver protein carbonyl content was
seen  (Fig. 2C). Since the lowering of nitric oxide levels began
by  24 h and reaction with reactive oxygen species such as
superoxide can scavenge NO due to formation of perox-
ynitrite [27], this was evaluated next by examination of
N-tyrosine formation. Interestingly, immunoﬂuorescence
staining of liver sections for N-tyrosine showed that the
intensity of nitration was slightly lower by 24 h when
compared to constitutive levels in controls and decreased
further by 48 h (Fig. 3A). To further examine if the decrease
in  NO was due to alterations in iNOS levels, this was  exam-
ined  by Western blotting. As seen in Fig. 3B, no signiﬁcant
change was seen in iNOS protein levels at the earlier times after administration of a single intra-peritoneal dose of 10 mg/kg body
 Liver histology at various time points after a single intra-peritoneal dose
points  after DMN  treatment, though a slight increase was
evident  by 72 h. This is probably due to the very low DMN
dosage in our study compared to earlier studies using DMN.
Another  cause of modulation of NO levels could be activ-
ity  of liver arginase, which could compete with NOS  for
arginine and shunt it to citrulline production instead of
NO  generation. But this also does not seem to be the case,
since  liver arginase enzyme activity was not altered after
DMN  administration (Fig. 3C). These data indicate that the
reduction  in NO levels subsequent to DMN  administration
was  not due to increased consumption by ROS or inhibition
of  iNOS, but probably due to lower steady-state levels of
the  molecule. The NOS isoform responsible for constitutive
levels of NO is endothelial NOS, which has been shown to
be  compromised during DMN-induced liver cirrhosis [28].
eNOS  mRNA levels were then examined and as seen in
Fig.  4A, a signiﬁcant decrease in eNOS expression was  evi-
dent  by 24 h after DMN, which remained suppressed even
at  48 h.
Hepatic  stellate cells have been implicated in modu-
lation of vascular tone due to their close proximity to
G. Jayakumar Amirtharaj et al. / Toxicology Reports 1 (2014) 707–717 711
Fig. 2. (A) Temporal course of nitrate levels in the liver after a single intra-peritoneal dose of 10 mg/kg body weight DMN. Values are mean ± SEM, n = 4.
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 = 4 (*p < 0.05). (C) Protein carbonyl content in the liver at various time p
inusoidal endothelial cells and treatment with higher
oses of DMN has been shown to induce HSC proliferation
25]. To evaluate if stellate cells were induced by the mod-
rate  liver injury seen after a single 10 mg/kg dose of DMN,
mmunoﬂuorescence staining for glial ﬁbrillary acidic pro-
ein  (GFAP), a marker for stellate cells in the liver [29] was
arried  out in liver sections of mice after DMN  treatment.
n elevation in stellate cell proliferation was evident by
4  h after induction of liver injury, which was ampliﬁed by
8  h and further increased by 72 h after DMN  administra-
ion (Fig. 4B). This suggests that a single dose of DMN  is
apable  of inducing stellate cell proliferation within 24 h,estimated by hepatic levels of malondialdehyde. Values are mean ± SEM,
er DMN  treatment. Values are mean ± SEM, n = 4 (*p < 0.05).
which  persists 3 days later, similar to that seen after mul-
tiple  doses as described earlier [25].
Stellate cell activation has been suggested to be involved
in  regulation of vascular tone by modulating synthesis of
H2S [30], which is now recognized as a vasoconstrictor
in the liver [10]. CBS and CSE are the two  main enzymes
involved in hydrogen sulﬁde synthesis, while mitochon-
drial rhodanese plays an important role in H2S degradation.
As seen in Fig. 5, examination of H2S synthesis and degrada-
tion  activity in the liver after DMN  administration indicates
that  while no signiﬁcant change is seen in the synthetic
reactions (Fig. 5A), H2S degradation could be compromised
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Fig. 3. (A) Immunoﬂuorescence staining for nitro-tyrosine in liver sections from mice at various time points after a single intra-peritoneal dose of 10 mg/kg
antitatio
5). (C) Abody  weight DMN. (B) Representative Western blot and densitometric qu
and  72 h after DMN  administration. Values are mean ± SEM, n = 3 (*p < 0.0
Values  are mean ± SEM, n = 4.
due to the initial loss of rhodanese activity by 24 h, which
recovers within 72 h (Fig. 5B). This could produce a tran-
sient  elevation of H2S levels after DMN  administration. To
examine  potential reasons for inhibition of mitochondrial
rhodanese activity within 24 h after DMN, oxidant stress
parameters were then examined in mice liver mitochon-
dria isolated after DMN  treatment. A signiﬁcant increase
in  both malondialdehyde and protein carbonyl content
(Fig.  6A and B) clearly indicates an oxidant stress in the
mitochondria after DMN. But does oxidant stress affect
rhodanese activity? This was then examined in a series
of  in vitro experiments, where normal mouse liver mito-
chondria was incubated with hydrogen peroxide (H2O2) to
stimulate  oxidant stress, following which rhodanese activ-
ity  was measured. As seen in Fig. 6C, a signiﬁcant inhibition
of  rhodanese activity was evident on exposure to H2O2,n of inducible nitric oxide synthase (iNOS) in liver homogenate at 24, 48
rginase activity in the liver at various time points after DMN  treatment.
indicating  that the enzyme is susceptible to oxidative dam-
age.  The role of hydrogen peroxide in the process was
conﬁrmed by repeating the experiments with the H2O2
scavenger, catalase, which completely reversed inhibition
of  rhodanese, indicating the decrease in activity was due to
oxidant  stress.
Secretion of pro-inﬂammatory cytokines such as IL1,
IL6  and TNF has been noted in activated rat HSCs [31] and
the  presence of inﬂammation was then examined in liver
samples  after DMN  treatment. As seen in Fig. 7A, a transient
elevation in myeloperoxidase activity was  evident, with a
peak  at 24 h, which reverted to control levels by 48 h. This
suggests that some pro-inﬂammatory cytokine release was
occurring  after HSC activation at 24 h. Cytokines such as IL-
1  have been shown to inﬂuence expression of proteins
involved in hemodynamics such as the von Willebrand
G. Jayakumar Amirtharaj et al. / Toxicology Reports 1 (2014) 707–717 713
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actor cleaving protease, ADAMTS13. Immunoﬂuorescence
taining revealed a signiﬁcant decrease in ADAMTS13 lev-
ls  within 24 h after DMN  administration, which started
ecovering by 48 h and almost reached control levels by
2  h (Fig. 7B).
. Discussion
Dimethylnitrosamine is an alkylating hepatotoxin
hich has been used extensively to induce chronic liver
njury,  where doses are typically repeated for a number
f  weeks to develop severe liver damage such as cirrho-
is  and hepatocarcinogenesis [32]. Dimethyl-nitrosamine
nduces liver necrosis and carcinogenesis by a number of
echanisms, which include calcium activated DNA frag-
entation [33] and activation of metalloproteases [34].ent with DMN. Values are mean ± SEM, n = 3 (*p < 0.05). (B) Immunoﬂu-
te cells in liver sections from mice at various time points after a single
Microcirculatory differences have been noted in DMN-
induced cirrhotic livers during ischemia–reperfusion [35]
and  intravascular coagulation has been shown to occur
in  DMN-induced liver injury [36]. Our ALT and histology
data suggests that a single 10 mg/kg body weight dose of
DMN  results in moderate liver injury within 24 h, which
begins to resolve by 48 h. This is probably expected, since
only  a single administration was  carried out, with no addi-
tional  treatments which could have sustained the injury. It
has  been shown earlier that 3 repeated daily administra-
tions of 10 mg/kg DMN  in rats resulted in ALT levels similar
to  our data, 24 h after the third injection [25]. This sug-
gests that the initial injury is similar with a either a single
injection or 3 repeated doses. But can this single moderate
insult affect intrahepatic vascular mediators such as nitric
oxide?
714 G. Jayakumar Amirtharaj et al. / Toxicology Reports 1 (2014) 707–717
Fig. 5. Activity of hydrogen sulﬁde synthetic enzymes (A) and rhodanese
(B) in liver homogenates at different time points after a single intraperi-
Fig. 6. Malondialdehyde (A) and protein carbonyl content (B) in liver
mitochondrial isolated 24 h after a 10 mg/kg dose of DMN  in mice. Val-
ues are mean ± SEM, n = 4 (*p < 0.05). (C) Mitochondrial rhodanese activity
gested  to have a vasodilatory effect in a number of organstoneal dose of 10 mg/kg body weight DMN. Values are mean ± SEM, n = 3
(*p  < 0.05).
This seems to be the case, since liver nitrate levels
began to drop at 24 h and a signiﬁcant decrease was obvi-
ous  at the 48 h time point, NO levels being suppressed
up to 72 h. But what was responsible for this continual
suppression in steady state NO levels after DMN  treat-
ment? Dimethylnitrosamine has been shown to elevate
reactive oxygen species in the liver [25] and our data also
demonstrated lipid peroxidation by 24 h after DMN  admin-
istration. Though NO could be scavenged by radicals such
as  superoxide to produce peroxynitrite [27], this does not
seem  to be the case in this instance, where interestingly,
constitutive nitrotyrosine levels were reduced after DMN.
Accompanied by the ﬁnding that iNOS levels or arginase
activity were also unaltered, this suggests that the low dose
DMN  treatment alters steady-state NO levels early dur-
ing  injury. The NOS isoform involved in constitutive NO
generation is endothelial NOS (eNOS), the hepatic levels of
which  have been shown to be altered in various liver disor-
ders  including NAFLD [37] and hepatic ischemia [38]. The
sustained decrease in eNOS mRNA beginning at 24 h after
DMN  treatment indicates that the lowering of NO levels
after  DMN  induced liver injury could be due to eNOS down
regulation. These data suggest that at least at this dose of
DMN,  NO production is a target and probably not a cause of
toxicity.  A reduction in nitric oxide production by endothe-
lial  cells has been shown in cirrhotic rat livers [39] and it
has  been demonstrated that activation of hepatic stellate
cells  is accompanied by decreased eNOS mRNA expression
as  well as protein [40].
Hepatic stellate cells are critical mediators of liver
injury, especially ﬁbrosis. Stellate cells are involved in reg-
ulating  sinusoidal vascular tone, and are also implicated in
the  pathogenesis of intrahepatic portal hypertension [41].after in vitro exposure of normal mitochondria to either 100 M H2O2
or 100 M H2O2 + catalase. Values are mean ± SEM, n = 3 (*p < 0.05 when
compared to control, #p < 0.05 when compared to H2O2).
In addition, the stellate cell is the main location for syn-
thesis of the ADAMTS13 protein [12,42], which is a critical
mediator in maintaining intrahepatic blood ﬂow and pre-
venting  a hypercoagulatory state. GFAP expression in the
liver  is an early marker of stellate cell activation [29], and
HSC  activation has been shown with repeated administra-
tions of DMN  [25]. Our data now shows that these cells are
exquisitely sensitive to even a single moderate insult, since
sustained HSC activation, was evident for up to 72 h after
a  single DMN  dose. Activated hepatic stellate cells have
been  shown to be crucially involved in portal hypertension
in cirrhosis, and targeted inhibition of stellate cell Rho-
kinase, which is involved in cellular contraction, decreased
ﬁbrosis and lowered portal pressure acutely without major
systemic  effects [43].
So  what consequences does this early activation of stel-
late  cells have on other vascular mediators? Stellate cell
activation has been shown to modulate levels of H2S in
the  liver [30], which is now recognized to be involved in
modulating vascular tone [10]. Though H2S has been sug-including the placenta [44], it has been recently shown to
induce  a vasoconstrictor effect on the hepatic sinusoid and
contribute to vascular resistance in the liver [10]. Portal
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 = 3 (*p < 0.05). (B) Immunoﬂuorescence staining for ADAMTS13 in liver
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nfusion of H2S has been shown to increase portal pressure
n  vivo and inhibition of cystathionine  lyase signiﬁcantly
ttenuated the sinusoidal sensitization to endothelin-1
n endotoxin-treated animals [10]. Our data with DMN
dministration suggests that the decrease in rhodanese
ctivity at 24 h, which would compromise H2S metabolism,
oupled with the stable generation of H2S, could result in a
ransient  elevation of the molecule at that time point. This,
oupled  with the decrease in the vasodilator NO could pro-
ide  a milieu for vascular resistance in the liver early after
MN.  But why is rhodanese activity selectively affected ini-
ially  after DMN? This is probably due to its localization in
he  mitochondria [45], an organelle in which oxidant stress
as  evident within 24 h after DMN  as indicated by the MDA
nd  protein carbonyl data. This is further supported by
ur  in vitro studies, which clearly indicate that rhodanese DMN  administration as a marker of inﬂammation. Values are mean ± SEM,
 from mice at various time points after a single intra-peritoneal dose of
activity is susceptible to oxidant stress. It has been shown
that  drugs such as atorvastatin increase perivascular adi-
pose  tissue-derived H2S by suppressing its mitochondrial
oxidation [46] and a lower rhodanese protein expression
has been shown to be signiﬁcantly associated with higher
mitochondrial superoxide production in monocytes [47].
The  data so far clearly indicates that even moderate
liver injury induced by a single administration of DMN
results in activation of stellate cells, along with modula-
tion of vasoactive molecules such as NO and H2S. However,
another hallmark of stellate cell activation is inﬂammation
[48], and the next question was whether this moderate
liver insult could affect inﬂammatory mediators induced
by  HSC activation? This seems to be the case, since an
elevation in myeloperoxidase activity was  evident 24 h
after  DMN, when HSC proliferation was initiated, along
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Fig. 8. Hypothetical model based on the observations of the present study
showing modulation of vasoactive mediators in the liver after DMN-
induced liver injury. A single low dose DMN  administration results in
activation of hepatic stellate cells, which induces a drop in steady-state NO
levels  through down regulation of eNOS expression. This is accompanied
by an induction of oxidant stress, which, probably through mitochon-
drial dysfunction, inhibits the H2S degrading enzyme rhodanese. These
changes are accompanied by a decrease in levels of the VWF-cleaving pro-
tease  ADAMTS13, probably due to activation of inﬂammatory mediators.
The compromised degradation of H2S could result in its elevation in the
liver, which, combined with the loss of NO as well as ADAMTS13 could
contribute to elevations in vascular resistance and a hyper-coagulatory
[
tion  and contributes to hepatic microcirculatory dysfunction during
endotoxemia, Am. J. Physiol.: Gastrointest. Liver Physiol. 304 (2013)state.
with oxidative stress and compromised rhodanese activ-
ity.  Cytokines such as IFN-, IL-4 and TNF-a dramatically
inhibit biosynthesis and secretion of ADAMTS13 protease
in  rat primary hepatic stellate cells and human endothelial
cells [49]. It has also been demonstrated that IL-1 signif-
icantly reduced ADAMTS-13 mRNA expression in human
microglia and astroglioma cells suggesting their role in the
haemostasis of the local microenvironment under inﬂam-
matory  conditions [50].
A few earlier studies have demonstrated that treatment
with 50 mg/kg dimethylnitrosamine induced signiﬁcant
changes in intravascular coagulation within the liver, with
observation of ﬁbrin clots in the hepatic sinusoids at 12 h
and  soluble ﬁbrin monomer complexes detected at 24 h
[36].  An extensive reduction in plasma factor VIIIC levels
and  peripheral platelets was seen after 18 and 24 h, respec-
tively,  only in the DMN  model [51]. These changes were
unique to DMN  treatment and not seen in animals treated
with  CCl4 [51]. Our data now shows that signiﬁcant alter-
ations  in additional coagulation factors such as ADAMTS13
are  also evident, even after much smaller doses of DMN.
The  effect of DMN  on NO levels is also relevant in this con-
text,  since NO is known to have a protective role against
thrombosis, by decreasing vascular resistance and inhibit-
ing  platelet aggregation and adhesion [52]. It has also been
demonstrated that inhibition of nitric oxide production
increases DMN-induced liver injury in rats by accelerating
intravascular coagulation [53].
[ogy Reports 1 (2014) 707–717
In conclusion, as shown in Fig. 8, we  show that moderate
liver injury induced by a single low dose of dimethyl-
nitrosamine has far reaching consequences on vascular
mediators in the liver. DMN-induced liver injury results in
activation  of hepatic stellate cells, and induces a drop in
steady-state NO levels due to inhibition of eNOS expres-
sion. These changes are accompanied by early induction
of  oxidant stress, which is probably responsible for com-
promised metabolism of another vasoactive mediator, H2S,
along  with a decrease in levels of the VWF-cleaving pro-
tease  ADAMTS13. The compromised degradation of H2S
could  result in its elevation in the liver, which, com-
bined with the loss of NO as well as ADAMTS13 could
contribute to elevations in vascular resistance and a hyper-
coagulatory state.
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